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Abstract
Genetic reprogramming of somatic cells to a pluripotent state (induced pluripotent stem cells or iPSCs) by over-expression
of specific genes has been accomplished using mouse and human cells. However, it is still unclear how similar human iPSCs
are to human Embryonic Stem Cells (hESCs). Here, we describe the transcriptional profile of human iPSCs generated without
viral vectors or genomic insertions, revealing that these cells are in general similar to hESCs but with significant differences.
For the generation of human iPSCs without viral vectors or genomic insertions, pluripotent factors Oct4 and Nanog were
cloned in episomal vectors and transfected into human fetal neural progenitor cells. The transient expression of these two
factors, or from Oct4 alone, resulted in efficient generation of human iPSCs. The reprogramming strategy described here
revealed a potential transcriptional signature for human iPSCs yet retaining the gene expression of donor cells in human
reprogrammed cells free of viral and transgene interference. Moreover, the episomal reprogramming strategy represents a
safe way to generate human iPSCs for clinical purposes and basic research.
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Introduction
Genetic reprogramming to a pluripotent state of mouse somatic
cells was first achieved by ectopic expression of four factors (Oct4,
Sox2, Klf4 and c-Myc) using retroviruses [1]. Such cells were
named induced pluripotent stem cells (iPSCs). Subsequently, this
method was applied to human cells using the same factors or a
different combination in a lentivirus vector (Oct4, Sox2, Lin28 and
Nanog) [2–5]. Both mouse and human iPSCs are similar to
embryonic stem cells (ESCs) with respect to their morphology, cell
behavior, gene expression, epigenetic status and differentiation
potential both in culture and in vivo. However, to date, a
comprehensive transcriptional analysis has not been reported
comparing human ESCs and iPSCs. One reason is that the
technology used to derived iPSCs is not ‘‘footprint-free’’ and thus,
subjected to transcriptional interference.
Viral vectors are known to affect the transcriptional profile from
target cells, altering their behavior and sometimes inducing
apoptosis [6]. Moreover, the reactivation of the viral transgene
was also implicated in tumorigenesis from iPSC-derived chimeric
mice [7]. Also, random integration may influence the molecular
signatures of iPSCs by interrupting regulatory regions in the
human genome. Interestingly, a transcriptional analysis revealed
that transgene expression from not completely silenced viral
vectors could, in fact, perturb global gene expression in hiPSCs
[8].
Several attempts were made to generate a viral-free, integration-
free iPSCs. The generation of iPSCs with later excision of
reprogramming factors was recently achieved; still, the genome
continues to be affected by random solo-LTR insertions from viral
vectors [8]. Mouse iPSCs were also generated by multiple
transient expression of Oct4, Sox2 and Klf4 from embryonic
fibroblasts at very low efficiency [9]. Recently, a two-step seamless
factor removal from iPSCs using transposase-stimulated excision
was recently reported [10,11]. Although evidence that the system
might work in human cells was presented, it needs further
validation in more rigorous pluripotent assays [10,11]. A
‘‘footprint-free’’ and highly efficient system of generating human
iPSCs would help to determine the molecular mechanism of
cellular reprogramming and accelerate the search for efficient
compounds that will replace the original factors without side
effects.
The timing of the reprogramming and the factors required seem
to vary depending on cellular context [12–17]. The susceptibility
of a somatic cell to reprogram may depend on how similar its
transcriptional profile is to ESCs. Of note, mouse neural stem cells
(NSCs) were reprogrammed using only one (Oct4) or two factors
(Oct4 and Klf4), due to the endogenously high expression of
pluripotent genes, such as Sox2 and c-Myc, as well as several
intermediate reprogramming markers [14,17,18]. Fibroblasts that
already carry the Oct4 transgene can be reprogrammed with
fewer factors, facilitating the study of nuclear reprogramming [19].
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Myc, iPSC generation is more efficient when the gene is present
[20,21]. Furthermore, recent data suggest that c-Myc expression
primes cells for iPSC conversion, accelerating the initial steps of
reprogramming to achieve high efficiency [22]. Such observations
prompted us to use human NSCs expressing c-Myc, as a model to
facilitate the generation of iPSCs and to study the reprogramming
steps.
Results
Oct4 and Nanog can reprogram human neural stem cells
Our starting material was a multipotent, karyotypically normal,
c-Myc-immortalized human NSC line derived from a tissue
sample of human midbrain (10 weeks of gestation). Our rationale
was that the elevated expression of c-Myc and Sox2 in these cells
might prompt them to reprogram more easily than reported for
other types. First, we examined whether the combination of Oct4
and Nanog would reprogram these cells to a pluripotent state
[23,24]. The human NSCs have a typical, undifferentiated neural
stem cell morphology when expanding as monolayers on laminin-
coated plates (Fig. 1A). NSCs were infected once with lentivirus
expressing Oct4 and Nanog (ON) and plated onto a layer of
irradiated mouse embryonic fibroblasts (MEFs) in human ESCs
(hESC) medium [25]. Individual cells positive for alkaline
phosphatase (AP), a marker for pluripotent cells, appear as early
as 4 days after infection (Fig. 1A, inset). Interestingly, the
efficiency was around 1–3%, as measured by the number of AP-
positive colonies, at 14 days post-infection. Single infection with
an empty control virus or Nanog alone did not produce any
colonies (Fig. 1B). In the first week after infection, hundreds of
small colonies grew rapidly and had hESC morphology (Fig. 1C,
D). Two weeks after infection, iPSC colonies with a mature
morphology similar to hESCs were distinguished from the
original NSC population (Fig. 1E–F). The NSCs-iPSC(ON)
colonies were then manually isolated and propagated under
feeder-free growth conditions on matrigel-coated dishes. They
expressed markers of undifferentiated ESCs, including Lin28,
TRA-1-60 and SSEA-4, confirming the genetic reprogramming
by the two factors, Oct4 and Nanog (Fig. 1G). Several iPSC
lineages were established from independent infections and
mechanically expanded for at least 20 passages while maintaining
a normal karyotype (data not shown).
A viral-free, integration-free reprogramming approach
To generate human iPSCs without the use of viral delivery
vectors or genomic insertions, the Oct4 and Nanog cDNAs were
independently cloned under the CMV promoter into a plasmid
(pCEP) with the trans-acting Epstein-Barr associated nuclear
antigen 1 (EBNA-1) gene and the cis-DNA element oriP. The
combination of EBNA-1 and oriP elements allows for a transient
extra-chromosomal (episomal) state, avoiding genetic integration
in human and non-human primate cells [26–30]. The constructs
also contain a mammalian selection marker (the hygromycin
resistant gene). Human NSCs were electroporated with equimolar
concentrations of the two episomal plasmids (pCEP-Oct4 and
pCEP-Nanog) or the EGFP-reporter plasmid and plated on MEFs
under hESC conditions (Fig. 2A). Previous data in the literature
suggested that reprogramming factors should be maintained for up
to 12 days during iPSC generation from mouse cells [31,32].
Hygromycin selection was maintained for only a week, but
transgene expression from the plasmid carrying the EGFP reporter
gene suggested that the plasmid remained in the cells for another
week before being eliminated (Figure S1). After 10–12 days, small
iPSC colonies were first noted. Colonies were mechanically
isolated and propagated under hESC conditions on matrigel. At
this point, some colonies seemed unstable, with a strong tendency
to spontaneously differentiate and form a heterogeneous popula-
tion of cells (Fig. 2B, C). Undifferentiated cells were manually
selected from differentiated cells according to morphology until a
homogeneous population of iPSCs was achieved (Fig. 2D). The
iPSC colonies were morphologically indistinguishable from
hESCs, forming tight colonies of cells with a large nucleus to
cytoplasm ratio and prominent nucleoli (Fig. 2E), and they did not
display the NSCs’ original cell morphology (Fig. 2F). The efficiency
was higher (0.1–1%) when compared to fibroblasts reprogrammed
with retroviruses. We established several cell lineages from three
independent transfection experiments and chose three lines (iPSC1,
iPSC2, iPSC3) for further characterization.
These three iPSC colonies expressed several pluripotent
markers and were able to form embryoid bodies (EBs) in vitro
(Fig. 2G, H). They were also able to express markers of the three
germ layers, suggesting that they re-established pluripotency at the
molecular and cellular levels (Fig. 2I). PCR DNA fingerprinting
confirmed their derivation from NSCs rather than from a
contaminating hESC line (Figure S2). All iPSC clones could be
successfully propagated for more than 30 passages while
maintaining a normal karyotype (data not shown). Plasmid
transfection may lead to random integration into the genome at
low frequency. To test for genomic integration of plasmid DNA,
we designed several sets of PCR primers to amplify various parts of
the vector and transgenes (Fig. 3A, B). Teratomas containing
derivatives from all three embryonic germ layers confirmed that
the hiPSCs (but not the original NPCs used) were pluripotent and
able to differentiate to complex tissues in two different experi-
mental settings (Fig. 2J and Figure S3). Additionally, southern
blot analyses did not detect integration of plasmids in these clones
(Fig. 3C). DNA from the transfected plasmids was not detected in
any established colony using either method, indicating a lack of
genomic insertion and suggesting that the episomal vectors had
been diluted from the cells over time.
Human iPSCs have similar levels of myc when compared
to hESCs
We then analyzed if myc levels from these iPSCs derived from
NSCs would change after reprogramming. Interestingly, despite
the fact that the NSCs were immortalized with ectoptic expression
of myc, the transcriptional activity of myc is higher in iPSCs
compared to NSCs. Moreover, iPSCs clones have similar myc
transcriptional levels to hESCs (Figure S4). Together, these
observations indicate that the myc expression will likely not
interfere with the global transcription profile on the iPSCs.
A transcriptional signature for human iPSCs
Next, we asked if the global molecular signatures of two
plasmid-free iPSC lines (iPSC1, iPSC2) resembled those of
available hESC lines, namely HUES6 and Cyt25. Gene expression
profiles measured using human genome Affymetrix Gene Chip
arrays were grouped by hierarchical clustering, and correlation
coefficients were computed for all pair-wise comparisons (Fig. 4A).
We observed that the two iPSCs lines were almost indistinguish-
able from each other and that the two hESC lines were also highly
similar to each other. Clearly, the iPSC and hESC lines were
globally more similar to each other than to the NSC line (Fig. 4A),
and combined with manual inspection of the gene expression of
several known pluripotent (Oct4, LIN28, Sox2 and Nanog) and
neural stem cell markers (Sox2, Nestin and Musashi2) as measured
Footprint-Free hIPSCs
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successful (Fig. 4A).
Despite the global similarity between iPSCs and hESCs, the
profiles were not completely indistinguishable, which led us to
study what the molecular differences were. Four independent (A
versus B) group-wise comparisons were performed to identify
differentially expressed genes: (i) iPSC versus hESC (1,952 Refseq-
annotated genes were significantly enriched in iPSCs versus
hESCs; 1,072 genes were enriched in hESCs versus iPSCs at
P,0.01 after correcting for multiple hypotheses testing); (ii) iPSC
versus NSC (3,347 genes were significantly enriched in iPSCs
versus NSCs; 2,959 genes were enriched in NSCs versus iPSCs);
(iii) hESC versus NSC (2,376 genes were significantly enriched in
hESCs versus NSCs; 2,541 genes were enriched in NSCs versus
hESCs); (iv) iPSC and hESC versus NSC (3,730 genes were
significantly enriched in iPSCs and hESCs, versus NSCs and 3,638
Figure 1. Efficient and rapid generation of iPSCs from human fetal NSCs using two factors. A, Morphology of human fetal NSCs before
lentiviral infection. Inset: after 3 days post-infection with Lenti-Oct4 and Lenti-Nanog, individual cells expressed alkaline phosphatase (AP). B, Example
of infected plates stained for AP at 14 days post-infection showing several AP-positive colonies. Control infection did not result in any AP-positive
colonies. C and D, Aspect of colonies 14 days after infection growing in MEFs. E, Established human iPSC colonies, with well-defined borders and
compact cells, are morphologically similar to hESCs. F, Typical image of iPSCs growing in feeder-free conditions. G, Representative
immunofluorescence analysis of iPSCs growing on matrigel. Clear expression of pluripotent markers is observed. Bar=150 mm.
doi:10.1371/journal.pone.0007076.g001
Footprint-Free hIPSCs
PLoS ONE | www.plosone.org 3 September 2009 | Volume 4 | Issue 9 | e7076Figure 2. Generation of virus-free, integration-free human iPSCs. A, Aspect of human NSCs after plasmid electroporation and plating on MEFs.
B andC, Some selected colonies display a strong differentiation tendency in feeder-free conditions. D, Established iPSC lines are morphologically similar
to hESCs. E, iPSCs have a large nucleus-to-cytoplasm ratio andprominent nucleoli when compared to original NSCs (F). G, Immunofluorescence analysis
of iPSCs growing on matrigel showed clear expression of typical ESC markers. H, In vitro differentiation of iPSCs into EBs. I, RT-PCR from undifferentiated
and EB-derived iPSCs showing expression of markers for all three primary germ cell layers. The hESCs Cyt25 was used as a benchmark. J, Hematoxylin
and eosin staining of teratoma sections generated from integration-free iPSC lines showing differentiation in three germ layers: goblet cells in gastro-
intestinal (GI) tract (endoderm); neural rosettes (ectoderm) and blood vessels, muscle and cartilage/bone (mesoderm). Bar=150 mm.
doi:10.1371/journal.pone.0007076.g002
Footprint-Free hIPSCs
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S1 to S8 contain the full list of comparisons). Restricting these
differentially expressed genes to ones that changed by at least 4-
fold in any comparison, at a stringent p-value cutoff of P,0.0001,
we identified three groups of biologically interesting genes. The
first group of iPSC-expressed genes was not sufficiently induced to
comparable levels as in hESCs and was still at their original levels
in NSCs (Fig. 4B). This group contained factors that were
important in early embryonic fate, such as Stella, ZFP42 (REX1),
CLDN10, LEFTY1 and LEFTY2. It is noteworthy that ZFP42
has been shown to be dispensable for pluripotency in mouse ES
cells [33], which may explain why the factor need not be induced
highly. Lefty1 has been shown to be important for pluripotency as
well [34], and it is downstream of Oct4 and Sox2, but perhaps
without the use of Klf4 the Lefty1 expression is not sufficiently
induced. The second group contained iPSC-expressed genes that
were not sufficiently repressed, such as ZIC1, OLIG2, EN2 and
PTX3, which were associated with the neuronal lineage (Fig. 4C).
The third group consisted of genes that were upregulated in iPSCs,
which were silenced in both NSCs and hESCs, suggesting that
these genes may be downstream factors in the reprogramming step
to induce pluripotent cells (Fig. 5). Overall, our transcriptome
analyses indicated that, whereas the iPSCs are globally similar to
hESCs, they are not indistinguishable, primarily due to the
insufficient suppression or induction of NSC-specific or early
embryonic-specific genes, respectively, as well as a class of genes
that was upregulated during the reprogramming step.
Oct4 alone is able to reprogram human NSCs
Next, we repeated the transient transfection using NSCs derived
from the H1 hESC line that contains the EGFP reporter cassette
knocked in the endogenous Oct4 gene by homologous recombi-
nantion [35]. The H1-Oct4-EGFP cell line expressed EGFP,
which turned off during differentiation (Fig. 6A). NSCs were
generated using our previous established protocol and consisted of
a cell population with a genetic profile distinct from both human
fetal cells and hESCs [36,37]. NSCs derived from the H1-EGFP
do not express EGFP (Fig. 6A). An EGFP-negative population of
NSCs, isolated by FACS, was electroporated with both episomal
plasmids carrying Oct4 and Nanog. Several iPSC colonies were
observed as early as 10 days after transfection, becoming
morphologically indistinguishable from the original H1-Oct4-
EGFP cell line (Fig. 6B, C). As a control, we electroporated the
same cell population with Oct4 only. Interestingly, we detected
several colonies when cells were transfected with Oct4 alone.
These colonies were positive for pluripotent makers, such as
Nanog and Lin28, suggesting efficient reprogramming (data not
shown). Our findings in human cells recapitulate recent data
demonstrating that Oct4 alone is sufficient to reprogram mouse
NSCs [17]. The observation that we could reprogram using only
Oct4 but not Nanog alone, suggests that Oct4 is likely an upstream
factor for cellular reprogramming. In fact, a previous study
suggests that Nanog may function to stabilize pluripotency rather
than being essential for the pluripotent stage [38].
Discussion
Using a simple methodology (Fig. 7), we demonstrated that it is
possible to generate human iPSCs at a high frequency without
viruses and with no evidence of genomic insertion. Human iPSCs
were achieved using transient episomal vectors carrying the
cDNAs for Oct4 and Nanog in a cell type that was likely more
prone to genetic reprogramming, such as NSCs. Also, we
demonstrated here for the first time that a myc-immortalized cell
line could be successfully reprogrammed, opening new avenues for
the study of several previously characterized immortalized cell
lines that are relevant for the biological understanding of several
disorders. The Myc-immortalized NSCs represent a reliable,
homogenous and commercially available tool to dissect individual
factors required for reprogramming. Myc levels after reprogram-
ming is similar to hESCs, thus it may be a better standard model
for fundamental reprogramming studies than fibroblasts. Further-
more, our data from hESC-derived NSCs indicate that repro-
gramming can be achieved without ectopic expression of the
tumor-associated genes, c-Myc and Klf4. Future studies will show
whether other sources of primary human NSCs can also be
efficiently reprogrammed by such non-viral methodology. Human
iPSCs generated by episomal vectors were then used to assess
whether human iPSCs and ESCs are really equivalent at the
molecular and functional levels, avoiding artifacts that may affect
their genetic signature, differentiation behavior or developmental
potential. Almost all previous studies have shown that the genetic
profile of human iPSCs is comparable, but never identical, to that
of hESCs. The slight differences between these two cellular
populations could be attributed to viral insertions in the genome or
incomplete genetic reprogramming. Our data suggest that,
although the global transcriptional profiles of hESCs and iPSCs
Figure 3. Absence of plasmid integration on virus-free iPSCs. A
and B, PCR analyses for plasmid integration in genomic DNA from the
iPSC clones. Controls: (2) water; (+) pCEP4 plasmid. Primers were
designed to specifically amplify plasmid backbone (A) or transgenes (B)
(see Methods). c, Southern blot (left) membrane hybridization of 10 mg
of BamHI-digested genomic DNA (see corresponding agarose gel on
right) using a DNA probe from the pCEP backbone. Plasmid DNAs of
pCEP-Oct4 and PCEP-Nanog, diluted to the equivalent of 0.5 integration
per genome, were used as controls for probe dilution. Lanes: M, DNA
molecular marker; 1- iPSC1; 2- iPSC2; 3- iPSC3; 4- NSCs (negative
control); 5- probe 25 rg; 6- probe 50 rg; 7- 100 rg; 8- 200 rg and 9- 50
gg. Arrow indicates expected probe size.
doi:10.1371/journal.pone.0007076.g003
Footprint-Free hIPSCs
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and cannot be attributed to random viral insertions in the genome.
Although we still do not know how relevant these differences are,
we anticipate that they may correspond to a unique differentiation
potential of iPSCs. Such a potential may also be dependent on the
original cell type and may suggest retention of the gene expression
memory of the donor cell in iPSCs. We recognize that the use of
the oncogene myc to immortalized NSCs might have caused
permanent epigenetic changes in the starting cell line that could be
carried over into the iPSC stage. The use of only one NSC line
further limits the conclusions of this work. Future experiments
using iPSCs reprogrammed by the episomal virus-free, transgene-
free strategy, in different original primary cell types is needed to
validate such hypothesis.
Our results support earlier observations that viral integration is
dispensable for genetic reprogramming [15,39]. Our data point to
the fact that viral integration does not facilitate iPSC generation,
and the efficiency is probably due to the duration and level of the
transgenes achieved with episomal plasmids. It has been estimated
that each cell contains as many as 50 copies of each episomal
plasmid in the nucleus [40]. After a critical amount of time,
selection is removed and the episomal vectors are eliminated from
the cells during duplication. Although we never detected episomal
plasmids in iPSC established colonies, eventual leftover plasmid
will likely be severely methylated when cells reach a pluripotent
state, avoiding excess transgene expression after reprogramming
[41]. In such a system, the amount and time of gene expression
can be easily controlled. We anticipate that different cell types will
require a distinct cocktail of pluripotent factors, under specific
timing and expression conditions. While this manuscript was in
preparation, a similar episomal strategy was used to reprogram
human primary fibroblasts using a distinct pluripotent cocktail of
factors, validating our methods, but with significant lower
efficiency (only 3 to 6 colonies/10
6 input cells) [42]. Finally, the
strategy described here may be a valuable tool for creating safer
patient-specific cells and thus could have major implications for
future cell therapy.
Materials and Methods
Ethics Statement
All animal work was conducted according to relevant national
and international guidelines. Protocols were previously approved
by the University of California San Diego Institutional Animal
Figure 4. Transcriptional analysis of human integration-free iPSC colonies. A, Hierarchical clustering and correlation coefficients of
microarray profiles of triplicate iPSC1, iPSC2, CytES (Cyt25 hESC), Hues6 and NSC. Color bar indicates the level of correlation (from 0 to 1). Panel below
illustrates marker genes implicated in pluripotency of NSCs, with color bar reporting log2 normalized expression values (green/red indicates high/low
relative expression). B, Refseq-annotated genes that were insufficiently induced in iPSCs relative to hESCs (yellow/blue indicates high normalized log2
expression). C, Refseq-annotated genes that were insufficiently silenced in iPSCs relative to hESCs.
doi:10.1371/journal.pone.0007076.g004
Footprint-Free hIPSCs
PLoS ONE | www.plosone.org 6 September 2009 | Volume 4 | Issue 9 | e7076Figure 5. Refseq-annotated genes that were upregulated in iPSCs relative to both hESCs and NSC. Panel illustrates marker genes
implicated in pluripotency of NSCs, with color bar reporting log2 normalized expression values (green/red indicates high/low relative expression).
doi:10.1371/journal.pone.0007076.g005
Footprint-Free hIPSCs
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Embryonic Stem Cell Research Oversight Committee.
Cell culture
Human fetal NSCs (ReNCell VM, Chemicon) were cultured on
laminin-coated dishes in ReNcell maintenance medium (Chemicon) in
the presence of basic fibroblast growth factor 2 (bFGF2), following the
manufacturer’s instructions. The hESC Cyt25 (Cythera, San Diego)
and HUES6 cell lines were cultured as previously described [25]. Two
days after infection/transfection, cells were plated on mitotically
inactivated MEFs (Chemicon), with hESCs medium, in the presence or
not of 50 mg/ml of hygromycin B (Invitrogen). After 2 weeks, iPSC
colonies were directly transferred to feeder-free conditions, on matrigel-
coated dishes (BD) using mTeSR
TM1 (StemCell Technologies).
Established iPSC colonies were kept in feeder-free conditions
indefinitely and passed using mechanical dissociation. EBs were
formed by mechanical dissociation of cell clusters and plating into low-
adherence dishes in hESC medium without bFGF2 for 7 days.
Figure 6. The dynamics of integration-free reprogramming. A, Undifferentiated H1 Oct4-EGFP hESC line expresses the EGFP reporter gene
that is gradually turned off during NSC differentiation. NSCs are morphologically distinct from hESCs. B, Small iPSC colonies can be detected 10 days
after transfection with pCEP-Oct4 and pCEP-Nanog. C, Typical number of iPSC colonies obtained with electroporation of pCEP-Oct4 and Nanog or
with Oct4 alone. Bar=150 mm.
doi:10.1371/journal.pone.0007076.g006
Footprint-Free hIPSCs
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Lentiviral vectors containing the Oct4 and Nanog human
cDNAs from Yamanaka’s group were obtained from Addgene.
The cDNAs were then subcloned into the pCEP4b episomal
plasmid (Invitrogen). Plasmid transfections were done by electro-
poration of equimolar amounts of pCEP-Oct4 and pCEP-Nanog
(5 mg each) using the nucleofactor for rat NSCs, following the
manufacturer’s instructions (Lonza/Amaxa Biosystem). Lentivi-
ruses were produced by triple transfection of HEK293T cells
followed by ultracentrifugation as previously described elsewhere
[25]. Fetal NSCs were infected with both Lenti-Oct4 and Lenti-
Nanog at a titer of 0.5610
10 gene transfer units/ml overnight,
followed by a 2-day recovery period before being plated on
mitotically inactive MEFs.
Immunocytochemistry
Cells were briefly fixed in 4% paraformaldehyde and then
permeabilized with 0.5% Triton-X in PBS. Cells were blocked in
0.5% Triton-X with 5% donkey serum for 1 hour before
incubation with primary antibody overnight at 4uC. After 3
washes in PBS, cells were incubated with secondary antibodies
(Jackson ImmunoResearch) for 2 hours at room temperature.
Fluorescent signals were detected using a Zeiss inverted micro-
scope and images were processed with Photoshop CS3 (Adobe
Systems). Primary antibodies used in this study are SSEA-4, TRA-
1-60, TRA-1-81 (1:100, Chemicon) and Lin28 (1:500 R&D
Systems). Alkaline phosphatase activity was detected in live cells
using the Vector Red Alkaline Phosphatase substrate kit (Vector
Laboratories).
Genomic PCR and Southern blot
Genomic DNA was isolated and prepared using standard
molecular techniques. The PCR primers were designed to
recognize the pCEP4 episomal vector (Invitrogene). The primers
pairs used to amplify the plasmid back bone were: CEP19-F: 59-
tatgatgacacaaaccccgcccag -39 and CEP19-R: 59- aaagcacga-
gattcttcgccctcc -39; CEP20-F: 59- gaaaaagcctgaactcaccgc -39 and
CEP20-R: 59- aaagcacgagattcttcgccctcc -39; CEP21-F: 59- ggcgaa-
gaatctcgtgctttc -39 and CEP21-R: 59- cggtgtcgtccatcacagtttg -39;
CEP22-F: 59- cgcaaggaatcggtcaatacactac -3 and CEP22-R: 59-
tccatacaagccaaccacgg -39; CEP23-F: 59- ggatttcggctccaacaatgtc -39
and CEP23-R: 59- tgaacaaacgacccaacaccc -39. The primers used
to amplify the transgene only were: CEP1-F1: 59- gcgtgga-
tagcggtttgactc -39; Oct4R1: 59- aaatccgaagccaggtgtc -39;
Figure 7. Schematic model of integration-free human iPSC generation from NSCs. Episomal plasmids carrying reprogramming factors are
transfected into NSCs and cells are plated on MEFs. On the following day, medium is changed to the hESC condition. Resistant selection is kept for a
week. After 14 days, iPSC colonies are visible and can be transferred to a feeder-free condition. Individual colonies are expanded and ready for
characterization. At this time, no evidence of plasmid integration is found.
doi:10.1371/journal.pone.0007076.g007
Footprint-Free hIPSCs
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genomic DNA, previously digested with BamHI, was performed
using standard molecular techniques. The probe used was a
fragment of pCEP4 plasmid cut with NruI and SalI enzymes.
RNA extraction and RT-PCR
Total cellular RNA was extracted from ,5610
6 cells using the
RNeasy Protect Mini kit (Qiagen, Valencia, CA), according to the
manufacturer’s instructions, and reverse transcribed using the
SuperScript III First-Strand Synthesis System RT-PCR from
Invitrogen. The cDNA was amplified by PCR using Accuprime
Taq DNA polymerase system (Invitrogene). The primer sequences
were: hNanog-Fw: 59 cctatgcctgtgatttgtgg 39 and hNanog-Rv: 59
ctgggaccttgtcttccttt 39; hBRACHYURY-F: 59 gccctctccctcccctcca-
cgcacag 39 and hBRACHYURY-R: 59 cggcgccgttgctcacagaccaca-
gg 39; hKRT-18-F: tctgtggagaacgacatcca and KRT-18-R: 59 ct-
gtacgtctcagctctgtga 39; h-AFP-F: 59 aaaagcccactccagcatc 39 and
AFP-R: 59 cagacaatccagcacatctc 39; GATA-4-F: 59 ctccttcaggcagt-
gagagc 39 and GATA-4-R: 59 gagatgcagtgtgctcgtgc 39; hGAPDH-
Fw: 59 accacagtccatgccatcac 39, hGAPDH-Rv: 59 tccaccaccctg-
ttgctgta 39. PCR products were separated by electrophoresis on a
2% agarose gel, stained with ethidium bromide and visualized by
UV illumination.
Teratoma formation in nude mice
Around 123610
6 cells were injected subcutaneously into the
dorsal flanks of nude mice (CByJ.Cg-Foxn1nu/J) anesthetized with
isoflurane. Five to 6 weeks after injection, teratomas were
dissected, fixed overnight in 10% buffered formalin phosphate
and embedded in paraffin. Sections were stained with haematox-
ylin and eosin for further analysis.
In vivo spinal iPSCs grafting and identification of
teratomas
Adult Sprague-Dawley male rats (320–350 g; n=6) were
anesthetized with isoflurane (1.5–2% maintenance; in room air),
placed into a spinal unit apparatus (Stoelting, Wood Dale, IL,
USA) and a partial Th12–L1 laminectomy performed using a
dental drill (exposing the dorsal surface of L2–L5 segments). Using
a glass capillary (tip diameter 80–100 mm) connected to a
microinjector (Kopf Instruments, Tujunga, CA), rats were injected
with 0.5 ml (10, 000 cells per injection) of the iPS (n=3) or
proliferating H9 cells in DMEF/F12 media. The duration of each
injection was 60 s followed by 30 s pause before capillary
withdrawal. The center of the injection was targeted into the
dorsal horn (distance from the dorsal surface of the spinal cord at
L3 level: 0.5–0.7 mm). Ten injections (500–800 mm rostrocaudally
apart) were made on each side of the lumbar spinal cord. After
injections, the incision was cleaned with penicillin-streptomycin
solution and sutured in two layers. Three or four weeks after cell
grafting, rats were deeply anesthetized with pentobarbital and
phenytoin and transcardially perfused with 200 ml of heparinized
saline followed by 250 ml of 4% paraformaldehyde in PBS. The
spinal cords were dissected and postfixed in 4% formaldehyde in
PBS overnight at 4uC and then cryoprotected in 30% sucrose PBS
until transverse sections (30 mm thick) were cut on a cryostat and
mounted on Silane-Prep slides (Sigma). Sections were stained with
H&E or immunostained overnight at 4uC with primary human
specific (h) or non-specific antibodies made in PBS with 0.2%
Triton-X100: mouse anti-nuclear matrix protein/h-nuc (hNUMA;
1:100; Millipore, Temecula, CA, USA); goat anti-doublecortin
(DCX; 1:1000; Millipore); mouse anti-Nestin (hNestin; Chemi-
con). After incubation with primary antibodies, sections were
washed 36 in PBS and incubated with fluorescent-conjugated
secondary donkey anti-mouse, or donkey anti-goat antibodies
(Alexa 488, 546; 1:250; Invitrogen Corp., Carlsbad, CA, USA)
and DAPI for general nuclear staining. Sections were then dried at
room temperature, covered with Prolong anti-fade kit (Invitrogen
Corp., Carlsbad, CA, USA) and analyzed with confocal
microscopy (Olympus, Fluoview 1000).
DNA fingerprinting
DNA fingerprinting analysis was performed by Cell Line
Genetics (Madison, WI).
Microarray analysis
The Affymetrix Power Tools (APT) suite of programs and
Affymetrix HG-U133 Plus 2.0 library files and annotation were
obtained from http://www.affymetrix.com/support. Gene-level
signal estimates were derived from the CEL files by RMA-sketch
normalization as a method in the apt-probeset-summarize
program. Hierarchical clustering of the full dataset of 15 (2 hiPSC
lines samples, 2 hESC lines, 1 NSC line in triplicate each) by
54,675 probeset values was performed by complete linkage
using Euclidean distance as a similarity metric in Matlab. The t-
statistic tA,B=(m A2mB)/sqrt (((nA21)s
2
A+(nB21)s
2
B)(nA+nB))/
((nAnB)( n A+nB22))), where nA and nB were the number of
replicates, mA and mB were the mean, and s
2
A and s
2
B were the
variances of the expression values for the two datasets, was
calculated representing the differential enrichment of a gene using
gene-level estimates in cell-type(s) A relative to cell-type(s) B.
Multiple hypothesis testing was corrected by controlling for the
false discovery rate (Benjamini-Hochberg). Four independent (A
versus B) comparisons were performed to identify differentially
expressed genes: (i) iPSCs versus hESCs; (ii) iPSCs versus NSCs;
(iii) hESCs versus NSCs; and (iv) iPSCs and hESCs versus NSCs.
A total of 653 probesets were retained at a stringent cutoff of
p,0.0001 and fold-change of 4. Probesets were centered by mean
expression values, and hierarchical clustering was performed by
complete linkage and uncentered correlation as the similarity
metric using Cluster 3.0 program. Results were visualized using
Java Treeview. Gene ontology analysis was performed as
described elsewhere [43].
Supporting Information
Figure S1 Sustained expression using episomal vectors. A,
Human fetal NSCs were electroporated with an episomal plasmid
carrying the EGFP reporter gene. Transfection efficiency was
around 95%. B, Percentage of cells expressing EGFP in the
presence or not of hygromycin. Bar=150 I ˆJm.
Found at: doi:10.1371/journal.pone.0007076.s001 (1.00 MB TIF)
Figure S2 Integration-free iPSC colonies are genetically identi-
cal to the original human fetal NSCs. DNA fingerprinting analysis
at 16 independent loci indicated that both iPSCs generated by
lentivirus infection (iPSC colony 19) and by transient transfection
with episomal vectors (iPSC colony 1) and the original human fetal
NSCs (ReNCell VM) shared all alleles investigated and were
different from commonly available hESC lines.
Found at: doi:10.1371/journal.pone.0007076.s002 (0.81 MB TIF)
Figure S3 Development of teratomas after spinal injections of
iPSCs into lumbar gray matter. Lumbar spinal cord sections were
stained with H&E at 3 weeks after grafting (A, B). The presence of
rosette-like structures (A, yellow arrow) and ectoderm-derived
squamous epithelium was identified (B, yellow arrow). Staining
with human-specific nestin (green) and DCX (red) antibody show
Footprint-Free hIPSCs
PLoS ONE | www.plosone.org 10 September 2009 | Volume 4 | Issue 9 | e7076well organized nestin positive cells in primitive neuronal tube and
numerous postmitotic DCX-positive neurons at the periphery of
grafts (C, D).
Found at: doi:10.1371/journal.pone.0007076.s003 (9.63 MB TIF)
Figure S4 Myc levels in neural stem cells before and after
reprogramming. The myc levels in iPSCs are similar to hESCs.
Found at: doi:10.1371/journal.pone.0007076.s004 (0.27 MB TIF)
Table S1 IPSC-enriched probes in IPSC versus ES. Probesets
enriched in group-wise comparisons: Column headings are
probeset identifiers, T-statistic, P-value, Fold-Change (log2),
Refseq identifier and Description of the gene. (NA indicates no
Refseq annotation).
Found at: doi:10.1371/journal.pone.0007076.s005 (5.43 MB
DOC)
Table S2 ES-enriched probes in IPSC versus ES. Probesets
enriched in group-wise comparisons: Column headings are
probeset identifiers, T-statistic, P-value, Fold-Change (log2),
Refseq identifier and Description of the gene. (NA indicates no
Refseq annotation).
Found at: doi:10.1371/journal.pone.0007076.s006 (2.66 MB
DOC)
Table S3 IPSC-enriched probes in IPSC versus NSC. Probesets
enriched in group-wise comparisons: Column headings are
probeset identifiers, T-statistic, P-value, Fold-Change (log2),
Refseq identifier and Description of the gene. (NA indicates no
Refseq annotation).
Found at: doi:10.1371/journal.pone.0007076.s007 (8.67 MB
DOC)
Table S4 NSC-enriched probes in IPSC versus NSC. Probesets
enriched in group-wise comparisons: Column headings are
probeset identifiers, T-statistic, P-value, Fold-Change (log2),
Refseq identifier and Description of the gene. (NA indicates no
Refseq annotation).
Found at: doi:10.1371/journal.pone.0007076.s008 (9.01 MB
DOC)
Table S5 ES-enriched probes in ES versus NSC. Probesets
enriched in group-wise comparisons: Column headings are
probeset identifiers, T-statistic, P-value, Fold-Change (log2),
Refseq identifier and Description of the gene. (NA indicates no
Refseq annotation).
Found at: doi:10.1371/journal.pone.0007076.s009 (6.06 MB
DOC)
Table S6 NSC-enriched probes in ES versus NSC. Probesets
enriched in group-wise comparisons: Column headings are
probeset identifiers, T-statistic, P-value, Fold-Change (log2),
Refseq identifier and Description of the gene. (NA indicates no
Refseq annotation).
Found at: doi:10.1371/journal.pone.0007076.s010 (7.45 MB
DOC)
Table S7 IPSC, ES-enriched probes in IPSC, ES versus NSC.
Probesets enriched in group-wise comparisons: Column headings
are probeset identifiers, T-statistic, P-value, Fold-Change (log2),
Refseq identifier and Description of the gene. (NA indicates no
Refseq annotation).
Found at: doi:10.1371/journal.pone.0007076.s011 (10.18 MB
DOC)
Table S8 NSC-enriched probes in IPSC, ES versus NSC.
Probesets enriched in group-wise comparisons: Column headings
are probeset identifiers, T-statistic, P-value, Fold-Change (log2),
Refseq identifier and Description of the gene. (NA indicates no
Refseq annotation).
Found at: doi:10.1371/journal.pone.0007076.s012 (12.08 MB
DOC)
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